October 4, 2022
Novartis CEO Vas Narasimhan Novartis is sharpening its focus on five therapeutic areas and four geographies as a pure-play innovative medicine player, pivoting its portfolio towards biologics and newer modalities. While the US is the top priority for the Swiss...read more